Use of Armodafinil for Fatigue in Sarcoidosis

• Status: Completed
• Trial end date: 2011-08-01
• Target enrollment: 0
• Participant gender: All

Summary

To determine the effect of Armodafinil (Nuvigil) on fatigue and sleep in sarcoidosis.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Cincinnati
• Collaborator: Cephalon
• Treatments: Armodafinil; Modafinil

Criteria

Inclusion Criteria:

• Diagnosis of sarcoidosis using standard criteria 15.

• Disease for more than one year

• On stable, systemic therapy

• Complain of fatigue which has been present for more than six months.

• Over 18 years of age

• Provide written informed consent.

Exclusion Criteria:

• Pregnancy

• Change in therapy for sarcoidosis in prior three months

• History of ventricular arrythmias